Bibliografia UJ CM

1/3
Jorge Cortes, Jane F. Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Arthur, Lori J. Maness, Moshe Talpaz, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia : a randomized, open-label phase 2 clinical trial.
Blood
2021 : Vol. 138, nr 21, s. 2042-2050
Auto korespondencyjny: Jorge Cortes.
p-ISSN: 0006-4971
e-ISSN: 1528-0020
AZ
ORG
AIF
IF: 25.669
Adres url:
Streszczenie w PubMed:
DOI:
2/3
Markus Pfirrmann, Richard E. Clark, Witold Prejzner, Michael Lauseker, Michele Baccarani, Susanne Saussele, François Guilhot, Sonja Heibl, Rüdiger Hehlmann, Edgar Faber, Anna Turkina, Gert Ossenkoppele, Martin Hoglund, Andrey Zaritskey, Boris Labar, Laimonas Griskevicius, Tomasz Sacha, Ulla Olsson-Strömberg, Daniela Zackova, Hele Everaus, Francisco Cervantes, Perttu Koskenvesa, Adriana Colita, Irena Zupan, Andrija Bogdanovic, Fausto Castagnetti, Joelle Guilhot, Joerg Hasford, Andreas Hochhaus, Verena S. Hoffmann.
The EUTOS long-term survival (ELTS) score is superior to the Sokalscore for predicting survival in chronic myeloid leukemia.
Leukemia
2020 : Vol. 34, nr 8, s. 2138-2149
Autor korespondencyjny: Markus Pfirrmann.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0887-6924
AZ
ORG
AIF
IF: 11.528
Adres url:
Streszczenie w PubMed:
3/3
Michael Lauseker, Katharina Bachl, Anna Turkina, Edgar Faber, Witold Prejzner, Ulla Olsson-Stromberg, Michele Baccarani, Elza Lomaia, Daniela Zackova, Gert Ossenkoppele Ossenkoppele, Laimonas Griskevicius, Gabriele Schubert-Fritschle, Tomasz Sacha, Sonja Heibl, Perttu Koskenvesa, Andrija Bogdanovic, Richard E. Clark, Joelle Guilhot, Verena S. Hoffmann, Joerg Hasford, Andreas Hochhaus, Markus Pfirrmann.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
American Journal of Hematology
2019 : Vol. 94, nr 11, s. 1236-1243, il., bibliogr. 34 poz., abstr.
Autor korespondencyjny: Michael Lauseker.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0361-8609
AZ
ORG
AIF
IF: 6.973
Adres url:
Streszczenie w PubMed:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ